Trends in hysterectomy-corrected uterine cancer mortality rates during 2002 to 2015: mortality of nonendometrioid cancer on the rise?

International Journal of Cancer. Journal International Du Cancer
Line W GustafsonAnne Hammer

Abstract

Corpus uteri cancer is the most common gynecological malignancy in most developed countries. The disease is typically diagnosed at an early stage, is of endometrioid histologic subtype, and has a fairly good prognosis. Here, we describe hysterectomy-corrected mortality rates of corpus uteri cancer, overall and stratified by age, stage and histologic subtype. Using data from nationwide Danish registries, we calculated uncorrected and hysterectomy-corrected age-standardized mortality rates of corpus uteri cancer among women ≥35 years during 2002 to 2015. Individual-level hysterectomy status was obtained from national registries; hysterectomy-corrected mortality rates were calculated by subtracting posthysterectomy person-years from the denominator, unless hysterectomy was performed due to corpus uteri cancer. Correction for hysterectomy resulted in a 25.5% higher mortality rate (12.3/100000 person-years vs 9.8/100000 person-years). Mortality rates were highest in women aged 70+, irrespective of year of death, histologic subtype and stage. A significant decline was observed in overall hysterectomy-corrected mortality rates from 2002 to 2015, particularly among women aged 70+. Mortality rates of endometrioid cancer declined signifi...Continue Reading

References

Feb 1, 1983·Gynecologic Oncology·J V Bokhman
Jan 29, 2000·Statistics in Medicine·H J KimD N Midthune
May 10, 2005·International Journal of Cancer. Journal International Du Cancer·Freddie BrayElisabete Weiderpass
May 17, 2005·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Freddie BrayElisabete Weiderpass
Dec 13, 2006·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·W T CreasmanS Pecorelli
Nov 6, 2007·American Journal of Obstetrics and Gynecology·Maura K WhitemanPolly A Marchbanks
Dec 7, 2007·The Journal of Steroid Biochemistry and Molecular Biology·A DollJ Reventós
Nov 27, 2008·Journal of the National Cancer Institute·Pierluigi Benedetti PaniciCostantino Mangioni
Jan 14, 2009·Acta Obstetricia Et Gynecologica Scandinavica·Cecilia LundholmDaniel Altman
Oct 7, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joan L WalkerSudarshan K Sharma
Feb 18, 2010·International Journal of Cancer. Journal International Du Cancer·Kristina LindemannFreddie Bray
Jun 5, 2010·The Australian & New Zealand Journal of Obstetrics & Gynaecology·Erin L HillJulia M Shelley
Jul 16, 2010·Cancer Causes & Control : CCC·Ashley S FelixFaina Linkov
Aug 4, 2011·Scandinavian Journal of Public Health·Karin Helweg-Larsen
Aug 4, 2011·Scandinavian Journal of Public Health·Marianne Lundkjær Gjerstorff
Nov 16, 2011·BJOG : an International Journal of Obstetrics and Gynaecology·M E DuncanM J Goldacre
Feb 1, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joan L WalkerSudarshan K Sharma
Nov 6, 2012·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Rebecca L SiegelAhmedin Jemal
Nov 28, 2012·European Journal of Obstetrics, Gynecology, and Reproductive Biology·D BollH C van Doorn
Apr 18, 2013·Cancer Epidemiology·Paige WartkoBritton Trabert
Aug 24, 2013·Obstetrics and Gynecology·Jason D WrightDawn L Hershman
Oct 8, 2013·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Rune LykkeHelga Gimbel
Jan 22, 2014·Acta Obstetricia Et Gynecologica Scandinavica·Mette C NoerClaus Høgdall
Mar 25, 2014·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Elisabete WeiderpassMarc Arbyn
Sep 16, 2014·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayFreddie Bray
Jan 13, 2015·Cancer Treatment Reviews·Martine T E PutsShabbir M Alibhai
Mar 1, 2015·American Journal of Obstetrics and Gynecology·Anne HammerMette Søgaard
Dec 5, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·N ColomboUNKNOWN ESMO-ESGO-ESTRO Endometrial Consensus Conference Working Group
Jan 20, 2016·Acta Oncologica·Anja Ør KnudsenUNKNOWN Academy of Geriatric Cancer Research (AgeCare)
Jun 20, 2017·Acta Obstetricia Et Gynecologica Scandinavica·Louise F WilsonGita D Mishra
Jan 23, 2018·Advances in Anatomic Pathology·W Glenn McCluggage
Nov 1, 2006·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·W T CreasmanS Pecorelli
Dec 7, 2018·MMWR. Morbidity and Mortality Weekly Report·S Jane HenleyLisa C Richardson
Jan 15, 2019·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Gitte ØrtoftMargit Dueholm
Jan 18, 2019·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Siv Lykke JørgensenPernille T Jensen
Mar 15, 2019·Acta Obstetricia Et Gynecologica Scandinavica·Anne HammerAnne F Rositch
May 23, 2019·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Megan A ClarkeNicolas Wentzensen

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.